89 related articles for article (PubMed ID: 28628288)
1. [The Mosan Study Group of Pigmented Tumours facing toward the oligometastatic cutaneous melanoma].
Piérard GE; Piérard-Franchimont C; Delvenne P
Rev Med Liege; 2017 Jun; 72(6):308-311. PubMed ID: 28628288
[TBL] [Abstract][Full Text] [Related]
2. Oligometastatic disease and visceral resections in advanced malignant melanoma: a propensity-matched analysis.
Urbanski A; Minnemann J; Mauch C; Schmidt T; Kreuzberg N; Schlaak M; Bruns CJ; Stippel DL; Wahba R
Langenbecks Arch Surg; 2023 Jan; 408(1):53. PubMed ID: 36680624
[TBL] [Abstract][Full Text] [Related]
3. [Relation between the prognosis of skin melanomas and the timing of appearance of regional metastases].
Vagner RI; Anisimov VV
Vopr Onkol; 1986; 32(10):21-5. PubMed ID: 3776125
[TBL] [Abstract][Full Text] [Related]
4. Modeling growth kinetics and statistical distribution of oligometastases.
Withers HR; Lee SP
Semin Radiat Oncol; 2006 Apr; 16(2):111-9. PubMed ID: 16564446
[TBL] [Abstract][Full Text] [Related]
5. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III).
Balch CM; Soong SJ; Murad TM; Smith JW; Maddox WA; Durant JR
J Clin Oncol; 1983 Feb; 1(2):126-34. PubMed ID: 6668496
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous melanoma and the Mosan Study Group of pigmented tumors. A step forward to trace invisible skin cancers and to offer better treatments.
Piérard GE; Piérard-Franchimont C; Claessens N; Arrese JE
Rev Med Liege; 2001; 56 Suppl():S1-6. PubMed ID: 11789383
[No Abstract] [Full Text] [Related]
7. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
[TBL] [Abstract][Full Text] [Related]
8. Treatment of brain metastases from melanoma.
McWilliams RR; Brown PD; Buckner JC; Link MJ; Markovic SN
Mayo Clin Proc; 2003 Dec; 78(12):1529-36. PubMed ID: 14661682
[TBL] [Abstract][Full Text] [Related]
9. Epiluminescence microscopy features of cutaneous malignant melanoma metastases.
Schulz H
Melanoma Res; 2000 Jun; 10(3):273-80. PubMed ID: 10890382
[TBL] [Abstract][Full Text] [Related]
10. Dermoscopic patterns of cutaneous melanoma metastases.
Rubegni P; Lamberti A; Mandato F; Perotti R; Fimiani M
Int J Dermatol; 2014 Apr; 53(4):404-12. PubMed ID: 24320196
[TBL] [Abstract][Full Text] [Related]
11. Skin metastases of malignant melanoma: a clinical and prognostic survey.
Savoia P; Fava P; Nardò T; Osella-Abate S; Quaglino P; Bernengo MG
Melanoma Res; 2009 Oct; 19(5):321-6. PubMed ID: 19641475
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
[TBL] [Abstract][Full Text] [Related]
13. FDG PET in early stage cutaneous malignant melanoma.
McIvor J; Siew T; Campbell A; McCarthy M
J Med Imaging Radiat Oncol; 2014 Apr; 58(2):149-54; quiz 266. PubMed ID: 24690243
[TBL] [Abstract][Full Text] [Related]
14. Melanoma progression.
Elder DE
Pathology; 2016 Feb; 48(2):147-54. PubMed ID: 27020387
[TBL] [Abstract][Full Text] [Related]
15. The miRNA machinery in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi.
Sand M; Skrygan M; Georgas D; Sand D; Gambichler T; Altmeyer P; Bechara FG
Cell Tissue Res; 2012 Oct; 350(1):119-26. PubMed ID: 22706980
[TBL] [Abstract][Full Text] [Related]
16. 211At-methylene blue for targeted radiotherapy of human melanoma xenografts: treatment of cutaneous tumors and lymph node metastases.
Link EM; Carpenter RN
Cancer Res; 1992 Aug; 52(16):4385-90. PubMed ID: 1643635
[TBL] [Abstract][Full Text] [Related]
17. Regional non-nodal metastases of cutaneous melanoma.
Cascinelli N; Bufalino R; Marolda R; Belli F; Nava M; Galluzzo D; Santinami M; Levene A
Eur J Surg Oncol; 1986 Jun; 12(2):175-80. PubMed ID: 3709823
[TBL] [Abstract][Full Text] [Related]
18. Do we have to pay more attention to vitiligo patients? Peculiar histopathological features of primary cutaneous melanoma preceded by vitiligo.
Onsun N; Büyükbabani N; Ummetoğlu O; Cebeci F
J Dermatol; 2009 Nov; 36(11):612-5. PubMed ID: 19878396
[TBL] [Abstract][Full Text] [Related]
19. Completely regressed primary cutaneous malignant melanoma with metastases.
Muniesa C; Ferreres JR; Moreno A; Marcoval J
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):327-8. PubMed ID: 18624860
[No Abstract] [Full Text] [Related]
20. Melanoma: Clinical Presentations.
Kibbi N; Kluger H; Choi JN
Cancer Treat Res; 2016; 167():107-29. PubMed ID: 26601860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
